Literature DB >> 12808167

Steroid therapy reduces mesangial matrix accumulation in advanced IgA nephropathy.

Minoru Kuriki1, Koichi Asahi, Kenichiro Asano, Kaoru Sakurai, Masaaki Eiro, Hodaka Suzuki, Kazuo Watanabe, Tetsuo Katoh, Tsuyoshi Watanabe.   

Abstract

BACKGROUND: Steroid therapy for IgA nephropathy (IgAN) has been reported to ameliorate the long-term prognosis of IgAN, but its mode of action has not been fully elucidated. In this study, we examined the effect of steroids on glomerular morphological changes in IgAN.
METHODS: We examined 16 patients with biopsy-proven IgAN (male/female =11/5, mean age 32.1 years) who were divided into prognosis groups according to criteria set by the Japanese Society of Nephrology. Initially, they received a loading dose of steroids, followed by a daily dose of 10-15 mg prednisolone. After 12 months, they underwent a second biopsy, and their histological and clinical features were examined.
RESULTS: Before and after therapy, systolic blood pressure, diastolic blood pressure, serum creatinine and creatinine clearance all remained unchanged. However, urinary protein excretion decreased dramatically, from 1.6+/-1.7 to 0.4+/-0.2 g/day (P<0.005). Furthermore, computerized imaging revealed a significant reduction of the mesangial matrix index (MMI) from 14.5+/-5.2 to 9.5+/-3.6% (P<0.001). The numbers of sclerosing glomeruli did not change.
CONCLUSIONS: Steroid therapy reduces mesangial matrix accumulation and reduces urinary protein excretion in advanced IgAN.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12808167     DOI: 10.1093/ndt/gfg135

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  4 in total

Review 1.  Why, when and how should immunosuppressive therapy considered in patients with immunoglobulin A nephropathy?

Authors:  F M Rasche; F Keller; W G Rasche; S Schiekofer; A Boldt; U Sack; J Fahnert
Journal:  Clin Exp Immunol       Date:  2016-09-08       Impact factor: 4.330

2.  Pathologic predictors of renal outcome and therapeutic efficacy in IgA nephropathy: validation of the oxford classification.

Authors:  Su-Fang Shi; Su-Xia Wang; Lei Jiang; Ji-Cheng Lv; Li-Jun Liu; Yu-Qing Chen; Sai-Nan Zhu; Gang Liu; Wan-Zhong Zou; Hong Zhang; Hai-Yan Wang
Journal:  Clin J Am Soc Nephrol       Date:  2011-08-18       Impact factor: 8.237

3.  Corticosteroids Should Be Used To Treat Slowly Progressive IgA Nephropathy: PRO.

Authors:  Amanda M Cunningham; Heather N Reich
Journal:  Kidney360       Date:  2021-02-05

4.  Genetical, histological, and clinical characteristics of IgA-negative mesangioproliferative glomerulopathy.

Authors:  Kazunori Owada; Hodaka Suzuki; Tetsuo Katoh; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2009-11-25       Impact factor: 2.801

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.